Morison commences local production of three high-in-demand medicines

0
27

Morison Ltd. commenced manufacturing of Bisoprolol tablets B.P. 5mg 250s, Ros-10 (Rosuvastatin tablets I.P. 10mg 30s blister), and ChlorMor (Chlorphenamine tablets B.P. 4mg 100s blister) recently. This marks a milestone in the local pharmaceutical industry, as these high-in-demand medicines are now more affordable and accessible to our people, the supply of which does not have to depend on imports, a spokesman said.    

For the first time in Sri Lanka, Bisoprolol 5 mg tablets are now being manufactured locally by Morison and supplied to the Medical Supplies Division for use in government hospitals. Used as a treatment for high blood pressure and other cardiovascular conditions, the annual requirement of Bisoprolol in the government sector is around 40 million tablets, which was being imported to date. By producing the same locally, Morison is able to make a significant forex saving for the national economy during these unprecedented times. Plans are underway to make Bisoprolol B.P. 2.5mg and 5 mg available in all leading pharmacies as a branded medication in due course, to enable purchasing through a valid prescription, he added.

The second new product launched, Ros-10 (Rosuvastatin tablets I.P. 10mg 30s blister) is used to treat high blood cholesterol, a risk factor for cardiovascular disease. Morison launched Ros-10 at approximately half of the current weighted average market price, offering significant savings to Sri Lankans. 

The third latest addition to the Morison portfolio, ChlorMor (Chlorphenamine tablets B.P. 4mg 100s blister) is an oral antihistamine that helps to relieve symptoms of allergies. This too was launched at a price less than the prevailing similar products in the market.

Being the first and largest general oral solid dosage (OSD) and oral liquid dosage (OLD) manufacturing facility in compliance with WHO GMP and EU GMP infrastructure and quality management systems in Sri Lanka, the Morison’s second manufacturing facility in Homagama, has the inbuilt capacity to produce 5 Bn tablets and 2 Mn litres of liquids per annum, which is equivalent to 40% of the national annual general OSD demand in Sri Lanka, the spokesman added.